Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Envarsus XR® in Adolescent Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Envarsus XR in adolescent kidney transplant recipients (active not recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Envarsus XR (Tacrolimus)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Kidney Transplantation, Renal Transplantation | Phase 4 | Status: ACTIVE_NOT_RECRUITING